LG life Science launches the first diabetes treatment combination drug in Korea
(Medipana)
LG Life Science finished the final price negotiation of diabetes treatment combination drug, ‘Gemimet,’ developed by its own technology and launched in local market.
LG Lif...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
